164 related articles for article (PubMed ID: 37503880)
21. Corpus callosum involvement and postoperative outcomes of patients with gliomas.
Chen KT; Wu TW; Chuang CC; Hsu YH; Hsu PW; Huang YC; Lin TK; Chang CN; Lee ST; Wu CT; Tseng CK; Wang CC; Pai PC; Wei KC; Chen PY
J Neurooncol; 2015 Sep; 124(2):207-14. PubMed ID: 26033546
[TBL] [Abstract][Full Text] [Related]
22. Mortality in children with low-grade glioma or glioneuronal tumors: A single-institution study.
Upadhyaya SA; Ghazwani Y; Wu S; Broniscer A; Boop FA; Gajjar A; Qaddoumi I
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28708330
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.
Dorris K; Sobo M; Onar-Thomas A; Panditharatna E; Stevenson CB; Gardner SL; Dewire MD; Pierson CR; Olshefski R; Rempel SA; Goldman S; Miles L; Fouladi M; Drissi R
J Neurooncol; 2014 Mar; 117(1):67-76. PubMed ID: 24477622
[TBL] [Abstract][Full Text] [Related]
24. Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma.
Nellan A; Wright E; Campbell K; Davies KD; Donson AM; Amani V; Judd A; Hemenway MS; Raybin J; Foreman NK; Rush S; Dorris K
J Neurooncol; 2020 Jul; 148(3):569-575. PubMed ID: 32506370
[TBL] [Abstract][Full Text] [Related]
25. BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.
Mistry M; Zhukova N; Merico D; Rakopoulos P; Krishnatry R; Shago M; Stavropoulos J; Alon N; Pole JD; Ray PN; Navickiene V; Mangerel J; Remke M; Buczkowicz P; Ramaswamy V; Guerreiro Stucklin A; Li M; Young EJ; Zhang C; Castelo-Branco P; Bakry D; Laughlin S; Shlien A; Chan J; Ligon KL; Rutka JT; Dirks PB; Taylor MD; Greenberg M; Malkin D; Huang A; Bouffet E; Hawkins CE; Tabori U
J Clin Oncol; 2015 Mar; 33(9):1015-22. PubMed ID: 25667294
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of distinct genetic entities in pediatric diffuse glioma WHO-grade II-Report from the German/Swiss SIOP-LGG 2004 cohort.
Falkenstein F; Gessi M; Kandels D; Ng HK; Schmidt R; Warmuth-Metz M; Bison B; Krauss J; Kortmann RD; Timmermann B; Thomale UW; Albert MH; Pekrun A; Maaß E; Gnekow AK; Pietsch T
Int J Cancer; 2020 Oct; 147(8):2159-2175. PubMed ID: 32239677
[TBL] [Abstract][Full Text] [Related]
27. A Case Report of Infant-Type Hemispheric Glioma with a Novel GAB1-ABL2 Kinase Fusion Treated with Dasatinib.
Buckner-Wolfson E; Jung G; Kim T; Fatemi R; Liriano G; Dalvi N; Behbahani M; Chin S; Martin A; Kobets A
Pediatr Neurosurg; 2024; 59(1):27-34. PubMed ID: 38109857
[TBL] [Abstract][Full Text] [Related]
28. MRI Features of Histologically Diagnosed Supratentorial Primitive Neuroectodermal Tumors and Pineoblastomas in Correlation with Molecular Diagnoses and Outcomes: A Report from the Children's Oncology Group ACNS0332 Trial.
Jaju A; Hwang EI; Kool M; Capper D; Chavez L; Brabetz S; Billups C; Li Y; Fouladi M; Packer RJ; Pfister SM; Olson JM; Heier LA
AJNR Am J Neuroradiol; 2019 Nov; 40(11):1796-1803. PubMed ID: 31601576
[TBL] [Abstract][Full Text] [Related]
29. Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas.
Guerreiro Stucklin AS; Ryall S; Fukuoka K; Zapotocky M; Lassaletta A; Li C; Bridge T; Kim B; Arnoldo A; Kowalski PE; Zhong Y; Johnson M; Li C; Ramani AK; Siddaway R; Nobre LF; de Antonellis P; Dunham C; Cheng S; Boué DR; Finlay JL; Coven SL; de Prada I; Perez-Somarriba M; Faria CC; Grotzer MA; Rushing E; Sumerauer D; Zamecnik J; Krskova L; Garcia Ariza M; Cruz O; Morales La Madrid A; Solano P; Terashima K; Nakano Y; Ichimura K; Nagane M; Sakamoto H; Gil-da-Costa MJ; Silva R; Johnston DL; Michaud J; Wilson B; van Landeghem FKH; Oviedo A; McNeely PD; Crooks B; Fried I; Zhukova N; Hansford JR; Nageswararao A; Garzia L; Shago M; Brudno M; Irwin MS; Bartels U; Ramaswamy V; Bouffet E; Taylor MD; Tabori U; Hawkins C
Nat Commun; 2019 Sep; 10(1):4343. PubMed ID: 31554817
[TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
[TBL] [Abstract][Full Text] [Related]
31. [Pediatric Hemispheric Glioma].
Nakano Y; Ichimura K; Sakamoto H
No Shinkei Geka; 2022 Jan; 50(1):122-131. PubMed ID: 35169092
[TBL] [Abstract][Full Text] [Related]
32. Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up.
Schepke E; Löfgren M; Pietsch T; Kling T; Nordborg C; Olsson Bontell T; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sabel M; Lannering B; Carén H
Clin Epigenetics; 2023 Mar; 15(1):40. PubMed ID: 36895035
[TBL] [Abstract][Full Text] [Related]
33. Conventional chemotherapy and perspectives for molecular-based oncological treatment in pediatric hemispheric low-grade gliomas.
Fernández MB; Alonso VP
Childs Nerv Syst; 2016 Oct; 32(10):1939-45. PubMed ID: 27659836
[TBL] [Abstract][Full Text] [Related]
34. Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations.
Boisseau W; Euskirchen P; Mokhtari K; Dehais C; Touat M; Hoang-Xuan K; Sanson M; Capelle L; Nouet A; Karachi C; Bielle F; Guégan J; Marie Y; Martin-Duverneuil N; Taillandier L; Rousseau A; Delattre JY; Idbaih A
Oncologist; 2019 Dec; 24(12):1584-1592. PubMed ID: 31346129
[TBL] [Abstract][Full Text] [Related]
35. Infant-Type Hemispheric Glioma in a Chinese Girl: A Newly Defined Entity.
Fang Y; Wang YZ; Wei X; Li SM; Chen L
Fetal Pediatr Pathol; 2023 Feb; 42(1):114-122. PubMed ID: 35404193
[TBL] [Abstract][Full Text] [Related]
36. Tectal glioma as a distinct diagnostic entity: a comprehensive clinical, imaging, histologic and molecular analysis.
Liu APY; Harreld JH; Jacola LM; Gero M; Acharya S; Ghazwani Y; Wu S; Li X; Klimo P; Gajjar A; Chiang J; Qaddoumi I
Acta Neuropathol Commun; 2018 Sep; 6(1):101. PubMed ID: 30253793
[TBL] [Abstract][Full Text] [Related]
37. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M
J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490
[TBL] [Abstract][Full Text] [Related]
38. A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma.
Su JM; Murray JC; McNall-Knapp RY; Bowers DC; Shah S; Adesina AM; Paulino AC; Jo E; Mo Q; Baxter PA; Blaney SM
Pediatr Blood Cancer; 2020 Jun; 67(6):e28283. PubMed ID: 32285998
[TBL] [Abstract][Full Text] [Related]
39. Recurrent pediatric central nervous system low-grade gliomas: the role of surveillance neuroimaging in asymptomatic children.
Udaka YT; Yeh-Nayre LA; Amene CS; VandenBerg SR; Levy ML; Crawford JR
J Neurosurg Pediatr; 2013 Feb; 11(2):119-26. PubMed ID: 23157391
[TBL] [Abstract][Full Text] [Related]
40. Bithalamic gliomas may be molecularly distinct from their unilateral high-grade counterparts.
Broniscer A; Hwang SN; Chamdine O; Lin T; Pounds S; Onar-Thomas A; Chi L; Shurtleff S; Allen S; Gajjar A; Northcott P; Orr BA
Brain Pathol; 2018 Jan; 28(1):112-120. PubMed ID: 28032389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
